Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A2QP
|
|||
Former ID |
DNC011641
|
|||
Drug Name |
N-Hydroxy-N-methyl-benzamide
|
|||
Synonyms |
N-Hydroxy-N-methylbenzamide; N-Hydroxy-N-methyl-benzamide; benzamide, N-hydroxy-N-methyl-; NSC646164; CHEMBL101043; 2446-50-6; AC1Q5INQ; n-methylbenzohydroxamic acid; AC1L83FX; N-Methyl-N-hydroxybenzamide; SCHEMBL125680; N-benzoyl-N-methylhydroxylamine; CTK0J4869; DTXSID20327327; DDSSLJHUWRMSSP-UHFFFAOYSA-N; ZINC5497333; BDBM50015122; AKOS028111405; NSC-646164
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C8H9NO2
|
|||
Canonical SMILES |
CN(C(=O)C1=CC=CC=C1)O
|
|||
InChI |
1S/C8H9NO2/c1-9(11)8(10)7-5-3-2-4-6-7/h2-6,11H,1H3
|
|||
InChIKey |
DDSSLJHUWRMSSP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 2446-50-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
Resolvin D biosynthesis | ||||
Leukotriene biosynthesis | ||||
Lipoxin biosynthesis | ||||
Aspirin triggered resolvin D biosynthesis | ||||
Aspirin triggered resolvin E biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Ovarian steroidogenesis | ||||
Toxoplasmosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Vitamin D Receptor Pathway | |||
Arachidonic acid metabolism | ||||
Eicosanoid Synthesis | ||||
Selenium Micronutrient Network |
References | Top | |||
---|---|---|---|---|
REF 1 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.